Topical and Oral Regimen for Skin Health
1 other identifier
interventional
74
1 country
1
Brief Summary
The overall objective of this study is to assess how oral supplementation with Inner Calm and the use of topical Super Calm can affect the appearance of skin and inner wellness, such as redness, skin sensitivity, and reactionary skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2020
CompletedFirst Submitted
Initial submission to the registry
October 9, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedMay 5, 2021
April 1, 2021
5 months
October 9, 2020
April 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in appearance of facial redness
Photographic image analysis
8 weeks
Changes in appearance of facial pigmentation
Photographic image analysis
8 weeks
Secondary Outcomes (8)
Changes in appearance of facial redness before and after treatment
8 weeks
Subjective report of skin reactivity
8 weeks
Subjective report of sleep quality and quantity
8 weeks
Subjective report of mood and energy
8 weeks
Subjective report of calmness of mind
8 weeks
- +3 more secondary outcomes
Study Arms (3)
InnerCalm+skin care
EXPERIMENTALAn oral supplement and topical agent will be assigned.
InnerCalm only
EXPERIMENTALAn oral supplement will be assigned.
Skincare Only
EXPERIMENTALA topical agent only will be assigned.
Interventions
Ashwagandha(Withania somnifera) root and leaf extract (32% Withania Oligosaccharides, 10% Withanolide Glycosides, 0.5% Withaferin A) 125 mg Saffron(Crocus Sativus) stigmas extract (3.48% Crocin and 0.03% Safranal) 28mg
Aqua/Water/Eau, Glycerin, Propanediol, Diheptyl Succinate, Caprylic/Capric Triglyceride, Lactococcus Ferment Lysate, Sorbitol, Dimethicone, Steareth-21, Octyldodecyl Neopentanoate, Sodium Polyacrylate, Steareth-2, Caprylyl Glycol, Hydrogenated Polydecene, Trideceth-6, Octyldodecanol, Panthenol, Sodium PCA, Azelaic Acid, Bisabolol, Capryloyl Glycerin/Sebacic Acid Copolymer, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Caprylhydroxamic Acid, Phytic Acid, Aminomethyl Propanol, Lactic Acid, Sodium Chloride, Phenoxyethanol, Sodium Benzoate.
Aqua/Water/Eau, Glycerin, Diisopropyl Dimer Dilinoleate, Coco-Caprylate, Lactococcus Ferment Lysate, Myristyl Myristate, Dimethicone, Propanediol, Behenyl Alcohol, Glyceryl Stearate SE, Potassium Cetyl Phosphate, Palmitic Acid, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Myristyl Laurate, Caprylyl Glycol, Hydroxyethylcellulose, Myristic Acid, Tocopherol, Ethylhexylglycerin, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Helianthus Annuus (Sunflower) Seed Oil, Trisodium Ethylenediamine Disuccinate, Lactic Acid, Sodium Hydroxide, Sodium Phosphate, Disodium Phosphate, Sodium Chloride, t-Butyl Alcohol, Phenoxyethanol, Sodium Benzoate.
Eligibility Criteria
You may qualify if:
- Women aged 18-55
- Fitzpatrick skin type 1-4
- Self-perception as sensitive skin
You may not qualify if:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant or breast-feeding women
- Prisoners
- Those who have used isotretinoin in the last 6 months
- Those who have used products containing salicylic acid, beta hydroxyl acids or vitamins A, C, or E or topical retinoids or topical depigmenting agents (such as hydroquinone, kojic acid, azelaic acid, or others in opinion of the investigator) in the last 14 days
- Those who are currently smoking or have smoked within the past 3 years.
- Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles, redness, or hyperpigmentation, such as botulinum toxin injections, chemical peels, laser-based therapies to the face, or face lift surgeries
- Subjects with known allergy to any of the components of Inner Calm or Skin Calm
- Those that are unwilling to discontinue use of any other nutritional supplements including antioxidants, herbs, or protein-based supplements for 2 weeks prior to and during their participation.
- Subjects with a diagnosis of acne
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Integrative Skin Science and Researchlead
- Arbonnecollaborator
Study Sites (1)
Integrative Skin Science and Research
Sacramento, California, 95815, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raja K Sivamani, MD
Integrative Skin Science and Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2020
First Posted
May 5, 2021
Study Start
November 26, 2019
Primary Completion
May 7, 2020
Study Completion
May 7, 2020
Last Updated
May 5, 2021
Record last verified: 2021-04